Primary cardiac angiosarcoma - a review.

Area of Science:

• Cardiovascular Pathology
• Oncology
• Diagnostic Imaging

Background:

• Primary cardiac neoplasms are exceptionally rare, with angiosarcoma being the most frequent histological subtype.
• Cardiac angiosarcoma is known for its aggressive, destructive nature and is often misdiagnosed initially due to its rarity.
• Despite decades since its identification, significant improvements in survival outcomes for cardiac angiosarcoma remain limited.

Purpose of the Study:

• To review the diagnostic modalities and current treatment strategies for primary cardiac angiosarcoma.
• To highlight the challenges in diagnosing and managing this rare malignancy.
• To discuss the role of imaging and immunohistochemistry in diagnosis and the limitations of current therapies.

Main Methods:

• Review of diagnostic tools including echocardiography, CT, and MRI for tumor detection and staging.
• Discussion of immunohistochemistry markers (CD31, CD34, FLI-1, von Willebrand factor) for diagnosing endothelial tumors.
• Analysis of treatment outcomes, focusing on surgical resection and the limited efficacy of chemotherapy and radiation.

Main Results:

• Echocardiography demonstrates high sensitivity for cardiac tumor diagnosis; CT and MRI are crucial for metastatic disease detection.
• Immunohistochemistry aids in identifying endothelial origin but can be variable due to tumor heterogeneity.
• Surgical resection is the primary palliative treatment, but complete cure is rare, and the tumor is largely resistant to chemotherapy and radiation.

Conclusions:

• Primary cardiac angiosarcoma is a rare, aggressive tumor requiring advanced imaging for diagnosis and staging.
• Surgical resection is the mainstay of treatment for palliation, with limited curative options.
• Further research is needed to establish the role of multimodal treatment regimens in improving outcomes for cardiac angiosarcoma.